Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations. Sourced from self-reported and de-identified data this product provides valuable insights about med combination trends.
Medisafe has a comprehensive database of de-identified medication adherence activity and behaviors. This product represents one subset of this data. To learn more about our insights- - contact us at dataaws@medisafe.com)
Product Overview: A snapshot of US Medisafe users who report taking a medication from specified class in the latest quarter of the current calendar year. This self-reported de-identified data includes gender and age characteristics as well as all their self-reported medications including supplements and over-the-counter medications. Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations.
Highlights
Drug Class: Antidepressants: SNRIs
Learn about combination trends additional medication patterns within a specific drug class.
Distribution of additional meds among the users in the specific drug class.
Data Period: 07/01/2019- 09/30/2019
Geographic coverage: USA
General Description:
Medisafe is the leader of digital therapeutic companions for medication management. Currently there are over six million users world-wide who have incorporated our holistic approach to medication management into their everyday lives. Medisafe has generated over 12 billion data points of de-identified data representing medication behaviors spanning diverse therapeutic areas. Medisafe’s data products are sourced from real-world behaviors while maintaining the highest degree of patient privacy and security protection. Our de-identified data sets combine age and gender demographics, self reported medication management and digital behavior patterns and is both HIPAA and GDPR compliant.
The data products offered on AWS are exclusively for qualified research endeavors. If interested in purchasing any of our data products we invite you to submit your request here dataaws@medisafe.com and we will reach out to discuss terms and prices.
Updated: December 5, 2019
Product subscription includes: initial snapshot file from most recent completed quarter of the year, and subsequent quarterly snapshots for duration of annual subscription. Product subscription renewed annually.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing is based on the duration and terms of your contract with the vendor. This entitles you to a specified quantity of use for the contract duration. If you choose not to renew or replace your contract before it ends, access to these entitlements will expire.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
This listing uses a single pricing dimension: Product Access, measured in Units. You buy access under a contract, and the Units quantity you commit to sets your cost. There are no separate tiers or instance sizes to choose between. Instead, pricing scales with the number of Units you subscribe to. This dimension grants subscribers access to the patient engagement product covering SNRI antidepressant therapy support. To match Units to your expected patient population or program scope, contact the vendor.
Top-of-mind questions for buyers
What does one Unit of Product Access represent for billing?
A Unit grants subscriber access to the patient engagement product for SNRI antidepressant therapy support. The marketplace listing does not define whether a Unit maps to a patient, a seat, or a program. To align Units with your patient population or program scope, contact the vendor.
What capabilities do I get with Product Access under this contract?
Access covers a branded, therapy-specific patient experience for SNRI support. This includes medication reminders, side-effect education, caregiver coordination, progress tracking, and omnichannel engagement across web, app, text, and voice. Predictive risk scoring and just-in-time interventions are part of the platform behind it.
How does my cost change if my patient program grows?
Cost scales with the number of Units you commit to under the contract. There are no separate tiers or instance sizes to cross. Adding scope means committing to more Units. The listing does not describe automatic overage behavior, so discuss growth planning with the vendor.
www.medisafe.com
Helpful?
Vendor refund policy
No refunds.
Can’t find a solution for your use case? Contact us at dataaws@medisafe.com
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Open-source NER model for species entities in biomedical and clinical text. Trained on Linnaeus and optimized for state-of-the-art precision, it enables reliable extraction with fast, easy deployment via Hugging Face Transformers.
Accelerate biomedical research with this free, open-source species NER model optimized for accurate extraction of species entities in clinical texts and research papers, surpassing licensed NER solutions.
Open-source NER model for chemical entities in biomedical and clinical text. Trained on BC5CDR-Chem and optimized for state-of-the-art precision, it enables reliable extraction with fast, easy deployment via Hugging Face Transformers.